This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Russell Johnson, Ph.D.
VP, Drug Delivery & Formulations at Omega Therapeutics


Russell Johnson, Ph.D., is a leading expert in mRNA and protein delivery. He currently serves as the Vice President of Delivery and Formulation at Omega Therapeutics, a clinical stage mRNA-focused healthcare company with a strategic focus on epigenetic regulation. He brings more than 14 years of industrial research and development experience in the delivery of RNA in preclinical and clinical programs. Prior to Omega, Russell was the Local-Head of Basic Pharmaceutical Sciences at GSK’s US-Vaccine Research center and worked across GSK’s vaccine technologies and platforms. He has deep experience with lipid, polymeric, and inorganic nanoparticles mRNA and nucleic acid delivery vehicles, with more than 40 peer-reviewed publications and two patents in mRNA delivery. He has led or assisted with seven drug candidates advancing to human clinical trials, with one receiving FDA approval and registration.

Agenda Sessions

  • Advancing mRNA-Based Epigenic Controllers in Human Disease